Skip to main content
Top
Published in: Rheumatology International 7/2008

01-05-2008 | Original Article

Comparison of the expression profile of apoptosis-associated genes in rheumatoid arthritis and osteoarthritis

Authors: Huang Qingchun, Huang Runyue, Jie LiGang, Chu Yongliang, Wei Song, Zhao Shujing

Published in: Rheumatology International | Issue 7/2008

Login to get access

Abstract

The purpose of this study was to employ microarray analysis to evaluate differential gene expression in synovial tissue samples obtained from patients with rheumatoid arthritis (RA) or osteoarthritis (OA) to study the expression profile of apoptosis-associated genes in these tissues. Four samples were obtained from RA-affected patients and three from osteoarthritis patients. After total RNA was extracted from synovial tissue, the RNA was processed using two-cycle target labeling, followed by hybridization and scanning procedure. The GeneChip Human Genome U133 Plus 2.0 containing 900471 gene loci was used and eight genes associated with apoptosis were identified with a selected p value <0.05 and a twofold change in expression in rheumatoid samples compared to osteoarthritis tissues. Anti-apoptotic genes were generally upregulated whereas apoptotic genes were downregulated suggesting that these genes may play a role in the pathogenesis of RA. Furthermore, these genes may serve as novel therapeutic targets for the treatment of RA.
Literature
1.
go back to reference Gay S, Gay RE, Koopman WJ (1993) Molecular and cellular mechanism of joint destruction in rheumatoid arthritis: two cellar mechanisms explain joint destruction. Ann Rheum Dis 52:39–47CrossRef Gay S, Gay RE, Koopman WJ (1993) Molecular and cellular mechanism of joint destruction in rheumatoid arthritis: two cellar mechanisms explain joint destruction. Ann Rheum Dis 52:39–47CrossRef
2.
go back to reference MacKenzie NM (2006) New therapeutics that treat rheumatoid arthritis by blocking T-cell activation. Drug Discov Today 11:952–956PubMedCrossRef MacKenzie NM (2006) New therapeutics that treat rheumatoid arthritis by blocking T-cell activation. Drug Discov Today 11:952–956PubMedCrossRef
3.
go back to reference Hui A, Kulkarni GV, Hunter WL, McCulloch CA, Cruz TF (1997) Paclitaxel selectively induces mitotic arrest and apoptosis in proliferating bovine synoviocytes. Arthritis Rheum 40:1073–1084PubMedCrossRef Hui A, Kulkarni GV, Hunter WL, McCulloch CA, Cruz TF (1997) Paclitaxel selectively induces mitotic arrest and apoptosis in proliferating bovine synoviocytes. Arthritis Rheum 40:1073–1084PubMedCrossRef
4.
go back to reference Nakajima T, Aono H, Hasunuma T, Yamamoto K, Shirai T, Hirohata K, Nishioka K (1995) Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 38:485–491PubMedCrossRef Nakajima T, Aono H, Hasunuma T, Yamamoto K, Shirai T, Hirohata K, Nishioka K (1995) Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 38:485–491PubMedCrossRef
5.
go back to reference Ceponis A, Hietanen J, Tamulaitiene M, Partsch G, Pätiälä H, Konttinen YT (1999) A comparative quantitative morphometric study of cell apoptosis in synovial membranes in psoriatic, reactive and rheumatoid arthritis. Rheumatology (Oxford) 38:431–440CrossRef Ceponis A, Hietanen J, Tamulaitiene M, Partsch G, Pätiälä H, Konttinen YT (1999) A comparative quantitative morphometric study of cell apoptosis in synovial membranes in psoriatic, reactive and rheumatoid arthritis. Rheumatology (Oxford) 38:431–440CrossRef
6.
go back to reference Kobayashi T, Okamoto K, Kobata T, Hasumuna T, Nishioka K (1999) Apomodulation as a novel therapeutic concept for the regulation of apoptosis in rheumatoid synoviocytes. Curr Opin Rheumatol 11:188–193PubMedCrossRef Kobayashi T, Okamoto K, Kobata T, Hasumuna T, Nishioka K (1999) Apomodulation as a novel therapeutic concept for the regulation of apoptosis in rheumatoid synoviocytes. Curr Opin Rheumatol 11:188–193PubMedCrossRef
7.
go back to reference Wolfe F, Michaud K (2007) Resistance of rheumatoid arthritis patients to changing therapy: discordance between disease activity and patients’ treatment choices. Arthritis Rheum 56:2135–2142 [Epub ahead of print]PubMedCrossRef Wolfe F, Michaud K (2007) Resistance of rheumatoid arthritis patients to changing therapy: discordance between disease activity and patients’ treatment choices. Arthritis Rheum 56:2135–2142 [Epub ahead of print]PubMedCrossRef
8.
go back to reference Bernatsky S, Hudson M, Suissa S (2007) Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis. Rheumatology (Oxford) 46:1157–1160CrossRef Bernatsky S, Hudson M, Suissa S (2007) Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis. Rheumatology (Oxford) 46:1157–1160CrossRef
9.
go back to reference Buch MH, Bingham SJ, Bryer D, Emery P (2007) Long-term infliximab treatment in rheumatoid arthritis: subsequent outcome of initial responders. Rheumatology (Oxford) 46:1153–1156CrossRef Buch MH, Bingham SJ, Bryer D, Emery P (2007) Long-term infliximab treatment in rheumatoid arthritis: subsequent outcome of initial responders. Rheumatology (Oxford) 46:1153–1156CrossRef
10.
go back to reference Mountz JD, Wu J, Cheng H, Zhou T (1994) Autoimmune disease: a problem of defective apoptosis. Science 37:1415–1420 Mountz JD, Wu J, Cheng H, Zhou T (1994) Autoimmune disease: a problem of defective apoptosis. Science 37:1415–1420
11.
go back to reference Ogawa N, Dang H, Hald N (1995) Apoptosis and autoimmunity. J Antoimmun 8:1–19CrossRef Ogawa N, Dang H, Hald N (1995) Apoptosis and autoimmunity. J Antoimmun 8:1–19CrossRef
12.
go back to reference Firestein GS, Nguyen K, Aupperle KR, Yeo M, Boyle DL, Zvaifler NJ (1996) Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am J Pathol 149:2143–2151PubMed Firestein GS, Nguyen K, Aupperle KR, Yeo M, Boyle DL, Zvaifler NJ (1996) Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am J Pathol 149:2143–2151PubMed
13.
go back to reference Triplett JW, Pavalko FM (2006) Disruption of alpha-actinin–integrin interactions at focal adhesions renders osteoblasts susceptible to apoptosis. Am J Physiol Cell Physiol 291:C909–C921PubMedCrossRef Triplett JW, Pavalko FM (2006) Disruption of alpha-actinin–integrin interactions at focal adhesions renders osteoblasts susceptible to apoptosis. Am J Physiol Cell Physiol 291:C909–C921PubMedCrossRef
14.
go back to reference Sasaki S, Nakamura T, Arakawa H, Mori M, Watanabe T, Nagawa H, Croce CM (2002) Isolation and characterization of a novel gene, hRFI, preferentially expressed in esophageal cancer. Oncogene 21:5024–5030PubMedCrossRef Sasaki S, Nakamura T, Arakawa H, Mori M, Watanabe T, Nagawa H, Croce CM (2002) Isolation and characterization of a novel gene, hRFI, preferentially expressed in esophageal cancer. Oncogene 21:5024–5030PubMedCrossRef
15.
go back to reference Sasaki S, Watanabe T, Konishi T, Kitayama J, Nagawa H (2004) Effects of expression of hRFI on adenoma formation and tumor progression in colorectal adenoma––carcinoma sequence. J Exp Clin Cancer Res 23:507–512PubMed Sasaki S, Watanabe T, Konishi T, Kitayama J, Nagawa H (2004) Effects of expression of hRFI on adenoma formation and tumor progression in colorectal adenoma––carcinoma sequence. J Exp Clin Cancer Res 23:507–512PubMed
16.
go back to reference Galvan V, Logvinova A, Sperandio S, Ichijo H, Bredesen DE (2003) Type 1 insulin-like growth factor receptor (IGF-IR) signaling inhibits apoptosis signal-regulating kinase 1 (ASK1). J Biol Chem 278:13325–13332PubMedCrossRef Galvan V, Logvinova A, Sperandio S, Ichijo H, Bredesen DE (2003) Type 1 insulin-like growth factor receptor (IGF-IR) signaling inhibits apoptosis signal-regulating kinase 1 (ASK1). J Biol Chem 278:13325–13332PubMedCrossRef
17.
go back to reference Zwerina J, Hayer S, Redlich K, Bobacz K, Kollias G, Smolen JS, Schett G (2006) Activation of p38 MAPK is a key step in tumor necrosis factor-mediated inflammatory bone destruction. Arthritis Rheum 54:463–472PubMedCrossRef Zwerina J, Hayer S, Redlich K, Bobacz K, Kollias G, Smolen JS, Schett G (2006) Activation of p38 MAPK is a key step in tumor necrosis factor-mediated inflammatory bone destruction. Arthritis Rheum 54:463–472PubMedCrossRef
18.
go back to reference Nakajima K, Hirose H, Taniguchi M, Kurashina H, Arasaki K, Nagahama M, Tani K, Yamamoto A, Tagaya M (2004) Involvement of BNIP1 in apoptosis and endoplasmic reticulum membrane fusion. EMBO J 23:3216–3226PubMedCrossRef Nakajima K, Hirose H, Taniguchi M, Kurashina H, Arasaki K, Nagahama M, Tani K, Yamamoto A, Tagaya M (2004) Involvement of BNIP1 in apoptosis and endoplasmic reticulum membrane fusion. EMBO J 23:3216–3226PubMedCrossRef
19.
go back to reference Mishra S, Murphy LJ (2006) The p53 oncoprotein is a substrate for tissue transglutaminase kinase activity. Biochem Biophys Res Commun 339:726–730PubMedCrossRef Mishra S, Murphy LJ (2006) The p53 oncoprotein is a substrate for tissue transglutaminase kinase activity. Biochem Biophys Res Commun 339:726–730PubMedCrossRef
20.
go back to reference Davila E, Kang YM, Park YW, Sawai H, He X, Pryshchep S, Goronzy JJ, Weyand CM (2005) Cell-based immunotherapy with suppressor CD8 + T cells in rheumatoid arthritis. J Immunol 174:7292–7301PubMed Davila E, Kang YM, Park YW, Sawai H, He X, Pryshchep S, Goronzy JJ, Weyand CM (2005) Cell-based immunotherapy with suppressor CD8 + T cells in rheumatoid arthritis. J Immunol 174:7292–7301PubMed
21.
go back to reference Ehinger M, Vestberg M, Johansson AC, Johannesson M, Svensson A, Holmdahl R (2001) Influence of CD4 or CD8 deficiency on collagen-induced arthritis. J Immunol 103:291–300CrossRef Ehinger M, Vestberg M, Johansson AC, Johannesson M, Svensson A, Holmdahl R (2001) Influence of CD4 or CD8 deficiency on collagen-induced arthritis. J Immunol 103:291–300CrossRef
22.
go back to reference Taneja V, Taneja N, Paisansinsup T, Behrens M, Griffiths M, Luthra H, David CS (2002) CD4 and CD8 T cells in susceptibility/protection to collagen-induced arthritis in HLA-DQ8-transgenic mice: implications for rheumatoid arthritis. J Immunol 168:5867–5875PubMed Taneja V, Taneja N, Paisansinsup T, Behrens M, Griffiths M, Luthra H, David CS (2002) CD4 and CD8 T cells in susceptibility/protection to collagen-induced arthritis in HLA-DQ8-transgenic mice: implications for rheumatoid arthritis. J Immunol 168:5867–5875PubMed
23.
go back to reference Mohan K, Pinto D, Issekutz TB (2003) Identification of tissue transglutaminase as a novel molecule involved in human CD8+ T cell transendothelial migration. J Immunol 171:3179–3186PubMed Mohan K, Pinto D, Issekutz TB (2003) Identification of tissue transglutaminase as a novel molecule involved in human CD8+ T cell transendothelial migration. J Immunol 171:3179–3186PubMed
24.
go back to reference Fan Z, Beresford PJ, Zhang D, Xu Z, Novina CD, Yoshida A, Pommier Y, Lieberman J (2003) Cleaving the oxidative repair protein Ape1 enhances cell death mediated by granzyme A. Nat Immunol 4:106–108CrossRef Fan Z, Beresford PJ, Zhang D, Xu Z, Novina CD, Yoshida A, Pommier Y, Lieberman J (2003) Cleaving the oxidative repair protein Ape1 enhances cell death mediated by granzyme A. Nat Immunol 4:106–108CrossRef
25.
go back to reference Su HP, Nakada-Tsukui K, Tosello-Trampont AC, Li Y, Bu G, Henson PM, Ravichandran KS (2002) Interaction of CED-6/GULP, an adapter protein involved in engulfment of apoptotic cells with CED-1 and CD91/low density lipoprotein receptor-related protein (LRP). J Biol Chem 277:11772–11779PubMedCrossRef Su HP, Nakada-Tsukui K, Tosello-Trampont AC, Li Y, Bu G, Henson PM, Ravichandran KS (2002) Interaction of CED-6/GULP, an adapter protein involved in engulfment of apoptotic cells with CED-1 and CD91/low density lipoprotein receptor-related protein (LRP). J Biol Chem 277:11772–11779PubMedCrossRef
26.
go back to reference Sharfe N, Dadi HK, Shahar M, Roifman CM (1997) Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc Natl Acad Sci USA 4:3168–3171CrossRef Sharfe N, Dadi HK, Shahar M, Roifman CM (1997) Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc Natl Acad Sci USA 4:3168–3171CrossRef
Metadata
Title
Comparison of the expression profile of apoptosis-associated genes in rheumatoid arthritis and osteoarthritis
Authors
Huang Qingchun
Huang Runyue
Jie LiGang
Chu Yongliang
Wei Song
Zhao Shujing
Publication date
01-05-2008
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 7/2008
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0534-7

Other articles of this Issue 7/2008

Rheumatology International 7/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.